HES
56
2
EQT
50
-4
EQIX
50
2
HP
33
3
AMG
75
4
ABT
35
-7
FOXA
66
2
AKAM
37
2
SBUX
39
2
HIG
54
3
JPM
57
2
EBAY
54
7
ORCL
63
4
MU
42
-5
ECL
59
2
FIS
55
9
ALL
40
-3
NDAQ
70
3
RF
58
2
O
30
-3
HES
56
2
EQT
50
-4
EQIX
50
2
HP
33
3
AMG
75
4
ABT
35
-7
FOXA
66
2
AKAM
37
2
SBUX
39
2
HIG
54
3
JPM
57
2
EBAY
54
7
ORCL
63
4
MU
42
-5
ECL
59
2
FIS
55
9
ALL
40
-3
NDAQ
70
3
RF
58
2
O
30
-3
Financhill
Back

Bolt Biotherapeutics 10K Form

Sell
26

BOLT
Bolt Biotherapeutics

Last Price:
$5.80
Seasonality Move:
-23.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BOLT News And Ratings

See the #1 stock for the next 7 days that we like better than BOLT

BOLT Financial Statistics

Sales & Book Value

Annual Sales: $7.7M
Cash Flow: $-13.4M
Price / Cash Flow: 0
Annual Sales: $24.42
Price / Book: 0.24

Profitability

EPS (TTM): -33.40000
Net Income (TTM): $-63.3M
Gross Margin: $34.4M
Return on Equity: -86.53%
Return on Assets: -56.37%

Bolt Biotherapeutics Earnings Forecast

Key Bolt Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 10 years for BOLT is 50.96%.
  • The Selling, General & Administrative Expenses for BOLT have been equal to 240.01% of Gross Profit Margin.
  • The Research & Development expenses have been 747.32% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of BOLT is -820.78% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 10 years.

Bolt Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BOLT
Website: boltbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.13
Quick Ratio: 2.86

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BOLT Technical Analysis vs Fundamental Analysis

Sell
26
Bolt Biotherapeutics (BOLT) is a Sell

Is Bolt Biotherapeutics a Buy or a Sell?